Ksalol 1 mg contains alprazolam, a benzodiazepine medication. In the United States, alprazolam is marketed under the brand name Xanax. FDA labeling identifies alprazolam as a benzodiazepine indicated for the acute treatment of generalized anxiety disorder in adults and for the treatment of panic disorder with or without agoraphobia in adults. Alprazolam tablets are available in 1 mg strength.
Alprazolam works on the central nervous system and can produce calming and sedative effects. Because it is a benzodiazepine, it carries important risks involving misuse, abuse, addiction, physical dependence, and withdrawal reactions. The FDA has a boxed warning regarding these risks. Abruptly stopping alprazolam after continued use can cause potentially serious or life-threatening withdrawal reactions, so discontinuation should be managed under medical supervision.
Alprazolam can cause drowsiness, dizziness, impaired coordination, and reduced alertness. Patients should use caution with activities such as driving or operating machinery. Alcohol and other central nervous system depressants can increase sedative effects and may create serious safety risks.
Particular caution is required when benzodiazepines such as alprazolam are used together with opioid medications. The FDA warns that combining benzodiazepines with opioids can result in profound sedation, respiratory depression, coma, and death. Such combinations should only be used when medically appropriate and under careful professional supervision.
Ksalol 1 mg is intended for prescription use and should only be taken according to the directions of a qualified healthcare professional. This information is provided for general educational purposes and is not a substitute for advice from a doctor or pharmacist.
